Imricor Medical Systems Inc (IMR) - Total Liabilities

Latest as of December 2025: AU$34.26 Million AUD ≈ $24.24 Million USD

Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has total liabilities worth AU$34.26 Million AUD (≈ $24.24 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Imricor Medical Systems Inc (IMR) equity growth momentum to track the company's year-over-year net asset growth rate.

Imricor Medical Systems Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Imricor Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data.

Imricor Medical Systems Inc Competitors by Total Liabilities

The table below lists competitors of Imricor Medical Systems Inc ranked by their total liabilities.

Company Country Total Liabilities
TUNGSTEN WEST PLC LS -01
F:540
Germany €76.26 Million
Hefei Taihe Optoelectronic
SHG:603656
China CN¥791.75 Million
Joyware Electronics Co Ltd
SHE:300270
China CN¥230.58 Million
Shandong Daye Co Ltd Class A
SHG:603278
China CN¥6.10 Billion
Healthcare Co Ltd
SHG:603313
China CN¥6.16 Billion
Duta Pertiwi Tbk
JK:DUTI
Indonesia Rp2.46 Trillion
ShenZhen Zero-Seven Co Ltd
SHE:000007
China CN¥173.46 Million
AnShan Heavy Duty Mining Machinery Co Ltd
SHE:002667
China CN¥2.17 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Imricor Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Imricor Medical Systems Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.47 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.97 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.75 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imricor Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imricor Medical Systems Inc (2016–2025)

The table below shows the annual total liabilities of Imricor Medical Systems Inc from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 AU$34.26 Million
≈ $24.24 Million
+18.12%
2024-12-31 AU$29.00 Million
≈ $20.52 Million
+69.98%
2023-12-31 AU$17.06 Million
≈ $12.07 Million
+175.61%
2022-12-31 AU$6.19 Million
≈ $4.38 Million
+38.68%
2021-12-31 AU$4.46 Million
≈ $3.16 Million
-6.09%
2020-12-31 AU$4.75 Million
≈ $3.36 Million
+36.27%
2019-12-31 AU$3.49 Million
≈ $2.47 Million
+34.78%
2018-12-31 AU$2.59 Million
≈ $1.83 Million
-68.63%
2017-12-31 AU$8.25 Million
≈ $5.84 Million
+10.08%
2016-12-31 AU$7.50 Million
≈ $5.30 Million
--

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices
Market Cap
$465.07 Million
AU$657.29 Million AUD
Market Cap Rank
#12467 Global
#326 in Australia
Share Price
AU$1.86
Change (1 day)
+0.00%
52-Week Range
AU$1.27 - AU$2.20
All Time High
AU$2.79
About

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more